274 related articles for article (PubMed ID: 18710953)
1. Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.
McKenna ES; Sansam CG; Cho YJ; Greulich H; Evans JA; Thom CS; Moreau LA; Biegel JA; Pomeroy SL; Roberts CW
Mol Cell Biol; 2008 Oct; 28(20):6223-33. PubMed ID: 18710953
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.
McKenna ES; Tamayo P; Cho YJ; Tillman EJ; Mora-Blanco EL; Sansam CG; Koellhoffer EC; Pomeroy SL; Roberts CW
Cell Cycle; 2012 May; 11(10):1956-65. PubMed ID: 22544318
[TBL] [Abstract][Full Text] [Related]
3. SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development.
Wei D; Goldfarb D; Song S; Cannon C; Yan F; Sakellariou-Thompson D; Emanuele M; Major MB; Weissman BE; Kuwahara Y
Mol Cancer Res; 2014 Nov; 12(11):1574-85. PubMed ID: 25009291
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
Isakoff MS; Sansam CG; Tamayo P; Subramanian A; Evans JA; Fillmore CM; Wang X; Biegel JA; Pomeroy SL; Mesirov JP; Roberts CW
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17745-50. PubMed ID: 16301525
[TBL] [Abstract][Full Text] [Related]
5. Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex.
Klochendler-Yeivin A; Picarsky E; Yaniv M
Mol Cell Biol; 2006 Apr; 26(7):2661-74. PubMed ID: 16537910
[TBL] [Abstract][Full Text] [Related]
6. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
Kim KH; Roberts CW
Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics and cancer: altered chromatin remodeling via Snf5 loss leads to aberrant cell cycle regulation.
Sansam CG; Roberts CW
Cell Cycle; 2006 Mar; 5(6):621-4. PubMed ID: 16582616
[TBL] [Abstract][Full Text] [Related]
9. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
10. Loss of Snf5 Induces Formation of an Aberrant SWI/SNF Complex.
Sen P; Luo J; Hada A; Hailu SG; Dechassa ML; Persinger J; Brahma S; Paul S; Ranish J; Bartholomew B
Cell Rep; 2017 Feb; 18(9):2135-2147. PubMed ID: 28249160
[TBL] [Abstract][Full Text] [Related]
11. Snf5 tumor suppressor couples chromatin remodeling, checkpoint control, and chromosomal stability.
Imbalzano AN; Jones SN
Cancer Cell; 2005 Apr; 7(4):294-5. PubMed ID: 15837618
[TBL] [Abstract][Full Text] [Related]
12. Highly penetrant, rapid tumorigenesis through conditional inversion of the tumor suppressor gene Snf5.
Roberts CW; Leroux MM; Fleming MD; Orkin SH
Cancer Cell; 2002 Nov; 2(5):415-25. PubMed ID: 12450796
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
Wang X; Lee RS; Alver BH; Haswell JR; Wang S; Mieczkowski J; Drier Y; Gillespie SM; Archer TC; Wu JN; Tzvetkov EP; Troisi EC; Pomeroy SL; Biegel JA; Tolstorukov MY; Bernstein BE; Park PJ; Roberts CW
Nat Genet; 2017 Feb; 49(2):289-295. PubMed ID: 27941797
[TBL] [Abstract][Full Text] [Related]
14. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
Darr J; Klochendler A; Isaac S; Eden A
Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
[TBL] [Abstract][Full Text] [Related]
15. Multiple interactions of the oncoprotein transcription factor MYC with the SWI/SNF chromatin remodeler.
Woodley CM; Romer AS; Wang J; Guarnaccia AD; Elion DL; Maxwell JN; Guerrazzi K; McCann TS; Popay TM; Matlock BK; Flaherty DK; Lorey SL; Liu Q; Tansey WP; Weissmiller AM
Oncogene; 2021 May; 40(20):3593-3609. PubMed ID: 33931740
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptors as novel therapeutic targets in SNF5-deleted malignant rhabdoid tumors.
Wöhrle S; Weiss A; Ito M; Kauffmann A; Murakami M; Jagani Z; Thuery A; Bauer-Probst B; Reimann F; Stamm C; Pornon A; Romanet V; Guagnano V; Brümmendorf T; Sellers WR; Hofmann F; Roberts CW; Graus Porta D
PLoS One; 2013; 8(10):e77652. PubMed ID: 24204904
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5(+/-);p53(+/-) mice.
DelBove J; Kuwahara Y; Mora-Blanco EL; Godfrey V; Funkhouser WK; Fletcher CD; Van Dyke T; Roberts CW; Weissman BE
Mol Carcinog; 2009 Dec; 48(12):1139-48. PubMed ID: 19676100
[TBL] [Abstract][Full Text] [Related]
18. The SWI/SNF chromatin-remodeling complex subunit SNF5 is essential for hepatocyte differentiation.
Gresh L; Bourachot B; Reimann A; Guigas B; Fiette L; Garbay S; Muchardt C; Hue L; Pontoglio M; Yaniv M; Klochendler-Yeivin A
EMBO J; 2005 Sep; 24(18):3313-24. PubMed ID: 16138077
[TBL] [Abstract][Full Text] [Related]
19. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival.
Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV
Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802
[TBL] [Abstract][Full Text] [Related]
20. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers.
Lee RS; Stewart C; Carter SL; Ambrogio L; Cibulskis K; Sougnez C; Lawrence MS; Auclair D; Mora J; Golub TR; Biegel JA; Getz G; Roberts CW
J Clin Invest; 2012 Aug; 122(8):2983-8. PubMed ID: 22797305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
